Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRCA1-mediated ubiquitylation.

Simon J Boulton1

  • 1DNA Damage Response Laboratory, Cancer Research UK, The London Research Institute, South Mimms EN6 3LD UK. simon.boulton@cancer.org.uk

Cell Cycle (Georgetown, Tex.)
|July 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct ATRX functions cooperate with 9-1-1 and CST complexes to safeguard replication and telomere integrity.

Nature structural & molecular biology·2026
Same author

H3K27M-driven hypertranscription leads to a new targetable dependency in diffuse midline gliomas.

bioRxiv : the preprint server for biology·2026
Same author

RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress.

Nature cell biology·2026
Same author

Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes.

Stem cell reports·2025
Same author

Cryo-electron microscopic visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2.

Science (New York, N.Y.)·2025
Same author

EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.

Nature communications·2025
Same journal

ALDH18A1 fuels spermine biosynthesis to sustain ferroptosis resistance in cancer and ischemia-reperfusion injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026
Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026
See all related articles

The BRCA1/BARD1 complex acts as an E3-ubiquitin ligase, crucial for DNA damage response and tumor suppression. Identifying its ubiquitylation targets is key to understanding BRCA1

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • BRCA1 and BARD1 proteins form a heterodimer essential for DNA damage response.
  • Their precise mechanism of action in cellular processes like transcription and cell cycle regulation is not fully understood.
  • The BRCA1/BARD1 complex functions as an E3-ubiquitin ligase, suggesting ubiquitylation of targets mediates its cellular roles.

Purpose of the Study:

  • To investigate the E3-ubiquitin ligase activity of the BRCA1/BARD1 complex.
  • To explore the conservation and regulation of BRCA1/BARD1 function in DNA damage response.
  • To identify critical targets of BRCA1-dependent ubiquitylation.

Main Methods:

  • Utilized studies in human cells and Caenorhabditis elegans.
  • Investigated the regulation of E3-ubiquitin ligase activity in response to DNA damage.

Related Experiment Videos

  • Focused on identifying substrates for BRCA1-mediated ubiquitylation.

    • Main Results:

    • BRCA1/BARD1 heterodimer functions as an E3-ubiquitin ligase.
    • BRCA1/BARD1 function is conserved in C. elegans.
    • Regulation of E3-ubiquitin ligase activity in response to DNA damage is understood.
    • Specific targets for BRCA1-dependent ubiquitylation remain unidentified.

    Conclusions:

    • The E3-ubiquitin ligase activity of BRCA1/BARD1 is critical for its tumor suppressor function.
    • Understanding the regulation of this ligase activity in response to DNA damage is advancing.
    • Identification of specific ubiquitylation targets is essential for elucidating BRCA1's role in tumorigenesis.